ctrl K

Price Alert

Pyxis Oncology Inc. (PYXS)

NASDAQ: PYXS · Real-Time Price · USD

1.21

0.08 (7.08%)

At close: Aug 15, 2025, 3:59 PM

1.21

0.00%

After-hours: Aug 15, 2025, 07:37 PM EDT

Pyxis Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	19.47M	9.66M	179.29M	274.74M
Short-Term Investments	107.46M	109.63M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	109K
Receivables	n/a	21K	598K	n/a
Inventory	n/a	n/a	874K	n/a
Other Current Assets	4.75M	4.27M	5.41M	2.17M
Total Current Assets	132.44M	124.6M	186.61M	278.67M
Property-Plant & Equipment	22.14M	24.81M	24.77M	1.24M
Goodwill & Intangibles	2.6M	24.31M	n/a	n/a
Total Long-Term Assets	24.74M	49.12M	24.77M	1.35M
Total Assets	157.18M	173.73M	211.38M	280.02M
Account Payables	4.86M	3.9M	7.1M	11.95M
Deferred Revenue	n/a	7.66M	n/a	6.33M
Short-Term Debt	n/a	n/a	n/a	165K
Other Current Liabilities	7.39M	7.75M	1.09M	3.06M
Total Current Liabilities	17.68M	25.76M	31.63M	18.71M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	18.75M	22.26M	18.92M	n/a
Total Liabilities	36.43M	48.02M	50.55M	18.71M
Total Debt	20.2M	21.33M	18.92M	165K
Common Stock	60K	45K	34K	32K
Retained Earnings	-363.56M	-286.23M	-212.44M	-91.72M
Comprehensive Income	170K	63K	n/a	-280.02M
Shareholders Equity	120.75M	125.7M	160.82M	261.31M
Total Investments	107.46M	109.63M	n/a	n/a